The association of metabolic syndrome with executive dysfunction independent of subclinical ischemic brain lesions in japanese adultsb

Dementia and Geriatric Cognitive Disorders

Volumn 30, Issue 6, 2011, Pages 479-485

  Bokura, Hirokazu ^a   Nagai, Atsushi ^a   Oguro, Hiroaki ^a   Kobayashi, Shotai ^b   Yamaguchi, Shuhei ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b SHIMANE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Brain lesions; Cognitive impairment; Executive function; Glucose metabolism; Metabolic syndrome

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; BODY MASS; BRAIN DAMAGE; BRAIN ISCHEMIA; COGNITION; COGNITIVE DEFECT; CORRELATION ANALYSIS; DEMOGRAPHY; DIET RESTRICTION; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; BODY MASS INDEX; BRAIN; BRAIN ISCHEMIA; CEREBRAL INFARCTION; COGNITION; COGNITION DISORDERS; DYSLIPIDEMIAS; EXECUTIVE FUNCTION; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERTENSION; IMAGE PROCESSING, COMPUTER-ASSISTED; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS;

EID: 79251492727     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322057     Document Type: Article

References (45)

1. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle- aged men. JAMA 2002; 288: 2709-2716.
2. Kurl S, Laukkanen JA, Niskanen L, Laaksonen D, Sivenius J, Nyyssonen K, Salonen JT: Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 2006; 37: 806-811.
3. Kwon HM, Kim BJ, Lee SH, Choi SH, Oh BH, Yoon BW: Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke 2006; 37: 466-470.
4. Bokura H, Yamaguchi S, Iijima K, Nagai A, Oguro H: Metabolic syndrome is associated with silent ischemic brain lesions. Stroke 2008; 39: 1607-1609.
5. Park K, Yasuda N, Toyonaga S, Yamada SM, Nakabayashi H, Nakasato M, Nakagomi T, Tsubosaki E, Shimizu K: Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology 2007; 69: 974-978.
6. Vicario A, Martinez CD, Baretto D, Diaz Casale A, Nicolosi L: Hypertension and cognitive decline: impact on executive function. J Clin Hypertens (Greenwich) 2005; 7: 598-604.
7. Qiu C, Winblad B, Fratiglioni L: The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005; 4: 487-499.
8. Skoog I, Gustafson D: Update on hypertension and Alzheimer's disease. Neurol Res 2006; 28: 605-611.
9. Kalmijn S, Foley D, White L, Burchfiel CM, Curb JD, Petrovitch H, Ross GW, Havlik RJ, Launer LJ: Metabolic cardiovascular syndrome and risk of dementia in Japanese- American elderly men. The Honolulu-Asia Aging Study. Arterioscler Thromb Vasc Biol 2000; 20: 2255-2260.
10. Staessen JA, Wang JG, Thijs L: Calciumchannel blockade and cardiovascular prognosis: recent evidence from clinical outcome trials. Am J Hypertens 2002; 15: 85S-93S.
11. MacKnight C, Rockwood K, Awalt E, Mc- Dowell I: Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian study of health and aging. Dement Geriatr Cogn Disord 2002; 14: 77-83.
12. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM: Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 1999; 53: 1937-1942.
13. Hassenstab JJ, Sweat V, Bruehl H, Convit A: Metabolic syndrome is associated with learning and recall impairment in middle age. Dement Geriatr Cogn Disord 2010; 29: 356-362.
14. Segura B, Jurado MA, Freixenet N, Albuin C, Muniesa J, Junque C: Mental slowness and executive dysfunctions in patients with metabolic syndrome. Neurosci Lett 2009; 462: 49-53.
15. Akbaraly TN, Kivimaki M, Shipley MJ, Tabak AG, Jokela M, Virtanen M, Marmot MG, Ferrie JE, Singh-Manoux A: Metabolic syndrome over 10 years and cognitive functioning in late midlife: the Whitehall II Study. Diabetes Care 2010; 33: 84-89.
16. Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hanninen T, Soininen H, Kervinen K, Kesaniemi YA, Laakso M, Kuusisto J: Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006; 67: 843-847.
17. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
18. Matsuzawa Y: Metabolic syndrome - definition and diagnostic criteria in Japan. J Atheroscler Thromb 2005; 12: 301.
19. Takahashi K, Bokura H, Kobayashi S, Iijima K, Nagai A, Yamaguchi S: Metabolic syndrome increases the risk of ischemic stroke in women. Intern Med 2007; 46: 643-648.
20. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S: Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997; 28: 1932-1939.
21. Fazekas F, Niederkorn K, Schmidt R, Offenbacher H, Horner S, Bertha G, Lechner H: White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke 1988; 19: 1285-1288.
22. Fukunishi I, Okabe S, Nakagawa T, Hosokawa K: The assessment of intelligence function of aged chronic schizophrenia. Jpn J Psychiatry Neurol 1990; 44: 503-509.
23. Okabe S: Simple intelligence assessment scale. Jpn J Clin Psychiat 1988; 17: 55-61.
24. Wigg CM, Duro LA: The Kohs' blocks test as an important instrument to investigate the visuo-spatial impairments in myotonic dystrophy. 1. Quantitative and qualitative analysis. Arq Neuropsiquiatr 1999; 57: 547-555.
25. Dubois B, Slachevsky A, Litvan I, Pillon B: The FAB: a Frontal Assessment Battery at bedside. Neurology 2000; 55: 1621-1626.
26. Mok VC, Wong A, Yim P, Fu M, Lam WW, Hui AC, Yau C, Wong KS: The validity and reliability of Chinese frontal assessment battery in evaluating executive dysfunction among Chinese patients with small subcortical infarct. Alzheimer Dis Assoc Disord 2004; 18: 68-74.
27. Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA: Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord 2007; 24: 185-192.
28. Yaffe K, Haan M, Blackwell T, Cherkasova E, Whitmer RA, West N: Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 2007; 55: 758-762.
29. Vermeer SE, Den Heijer T, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM: Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2003; 34: 392-396. (Pubitemid 36206336)
30. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC: Subcortical ischaemic vascular dementia. Lancet Neurol 2002; 1: 426-436.
31. Price CC, Jefferson AL, Merino JG, Heilman KM, Libon DJ: Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data. Neurology 2005; 65: 376-382.
32. Ylikoski R, Jokinen H, Andersen P, Salonen O, Madureira S, Ferro J, Barkhof F, van der Flier W, Schmidt R, Fazekas F, Scheltens P, Waldemar G, Salvadori E, Pantoni L, Inzitari D, Erkinjuntti T: Comparison of the Alzheimer's disEase Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS study. Dement Geriatr Cogn Disord 2007; 24: 73-81.
33. Teodorczuk A, O'Brien JT, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, Wallin A, Wahlund LO, Gouw A, Waldemar G, Schmidt R, Ferro JM, Chabriat H, Bazner H, Inzitari D: White matter changes and latelife depressive symptoms: longitudinal study. Br J Psychiatry 2007; 191: 212-217.
34. Yaffe K, Weston AL, Blackwell T, Krueger KA: The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol 2009; 66: 324-328.
35. Razay G, Vreugdenhil A, Wilcock G: The metabolic syndrome and Alzheimer disease. Arch Neurol 2007; 64: 93-96.
36. Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, Penninx BW: Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007; 30: 2655-2660.
37. Milionis HJ, Rizos E, Goudevenos J, Seferiadis K, Mikhailidis DP, Elisaf MS: Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects. Stroke 2005; 36: 1372-1376. (Pubitemid 40967496)
38. Erol A: An integrated and unifying hypothesis for the metabolic basis of sporadic Alzheimer's disease. J Alzheimers Dis 2008; 13: 241-253.
39. Watson GS, Craft S: Insulin resistance, inflammation, and cognition in Alzheimer's disease: lessons for multiple sclerosis. J Neurol Sci 2006; 245: 21-33.
40. Biessels GJ, Kappelle LJ: Increased risk of Alz heimer's disease in type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 2005; 33: 1041-1044.
41. Xie L, Helmerhorst E, Taddei K, Plewright B, Van Bronswijk W, Martins R: Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci 2002; 22:RC221.
42. Schuur M, Henneman P, van Swieten JC, Zillikens MC, de Koning I, Janssens AC, Witteman JC, Aulchenko YS, Frants RR, Oostra BA, van Dijk KW, van Duijn CM: Insulinresistance and metabolic syndrome are related to executive function in women in a large family-based study. Eur J Epidemiol 2010; 25: 561-568.
43. Geroldi C, Frisoni GB, Paolisso G, Bandinelli S, Lamponi M, Abbatecola AM, Zanetti O, Guralnik JM, Ferrucci L: Insulin resistance in cognitive impairment: the Inchianti Study. Arch Neurol 2005; 62: 1067-1072.
44. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ: The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995; 274: 1846-1851.
45. Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, McGovern P, Folsom AR: Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001; 56: 42-48.